Quoin Pharmaceuticals Ltd (NASDAQ:QNRX)
| 1.70 Delayed Data As of Dec 02 |  -0.03 / -1.73%Today’s Change | 1.57 Today|||52-Week Range 64.38 | -92.53% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $8.5M |
Company Description
Quoin Pharmaceuticals Ltd. is a specialty pharmaceutical company engaged in the development of therapeutic products for the treatment of rare and orphan diseases. The company was founded on March 5, 2018 and is headquartered in Kefar Sava, Israel.
Contact Information
Quoin Pharmaceuticals Ltd. 23 Hata'as Street Kefar Sava Tel Aviv 44425 |
Employees
Shareholders
| Other institutional | 2.49% |
| Mutual fund holders | 0.02% |
| Individual stakeholders | -- |
Top Executives
| Michael Myers | Chairman & Chief Executive Officer |
| Denise Carter | Chief Operating Officer & Director |
| Gordon B. Dunn | Chief Financial Officer |
